BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9589196)

  • 1. The benefits and risks of long-term PUVA photochemotherapy.
    Momtaz K; Fitzpatrick TB
    Dermatol Clin; 1998 Apr; 16(2):227-34. PubMed ID: 9589196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of psoralen photochemotherapy (PUVA).
    Wolff K
    Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photochemotherapy (PUVA): pro and con].
    Wolff K
    Hautarzt; 1985 Jan; 36(1):25-33. PubMed ID: 3918959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM
    Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.
    Doğan PE; Akay BN; Vural S; Arı C; Yılmaz TE; Şanlı H
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):428-434. PubMed ID: 36967646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
    Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
    Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus workshop on the toxic effects of long-term PUVA therapy.
    Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
    Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA).
    Moscicki RA; Morison WL; Parrish JA; Bloch KJ; Colvin RB
    J Invest Dermatol; 1982 Sep; 79(3):205-8. PubMed ID: 6809841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.